Neuren Pharmaceuticals (ASX:NEU) Ending Cash Position : A$17.1 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Neuren Pharmaceuticals Ending Cash Position?

Neuren Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 was A$17.1 Mil.

Neuren Pharmaceuticals's quarterly Ending Cash Position declined from Dec. 2022 (A$40.2 Mil) to Jun. 2023 (A$38.4 Mil) and declined from Jun. 2023 (A$38.4 Mil) to Dec. 2023 (A$17.1 Mil).

Neuren Pharmaceuticals's annual Ending Cash Position increased from Dec. 2021 (A$36.8 Mil) to Dec. 2022 (A$40.2 Mil) but then declined from Dec. 2022 (A$40.2 Mil) to Dec. 2023 (A$17.1 Mil).

Neuren Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Neuren Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuren Pharmaceuticals Ending Cash Position Chart

Neuren Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

13.85

24.19

36.78

40.18

17.09

Neuren Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															36.78	31.09	40.18	38.39	17.09

Neuren Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Neuren Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	40.18	+	-23.086
	=	17.1

Neuren Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	85.675	+	-68.581
	=	17.1

Neuren Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Neuren Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuren Pharmaceuticals (ASX:NEU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuren Pharmaceuticals Ltd (ASX:NEU) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

NURPF:USA

Address

697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.neurenpharma.com

Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome.